TriSalus Life Sciences, Inc.
SEC 4 · Filed
0001628280-26-007409Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 4, 2026
Grant, award or other acquisition by Stansky Michael P
- Security
- Director Stock Option (right to buy)
- Shares
-
92,537
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-02-04",
"direction": "A",
"exercise_price": "4.91",
"expiration": "2036-02-03",
"footnotes": {
"F1": "The shares subject to this stock option vest in three equal annual installments commencing on February 4, 2027, subject to the Reporting Person\u0027s continued service with the Issuer on each respective vesting date."
},
"owners": [
{
"cik": "0001424204",
"name": "Stansky Michael P",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "92537",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Director Stock Option (right to buy)",
"shares": "92537",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "92537"
}